374 related articles for article (PubMed ID: 28592210)
1. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
2. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
3. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
Phillips P; Chan K; Hogg R; Bessuille E; Black W; Talbot J; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2002 Feb; 34(3):371-8. PubMed ID: 11774085
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Karakousis PC; Moore RD; Chaisson RE
Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
Faris MA; Raasch RH; Hopfer RL; Butts JD
Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
[TBL] [Abstract][Full Text] [Related]
10. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
Rossi M; Flepp M; Telenti A; Schiffer V; Egloff N; Bucher H; Vernazza P; Bernasconi E; Weber R; Rickenbach M; Furrer H;
Swiss Med Wkly; 2001 Aug; 131(31-32):471-7. PubMed ID: 11641970
[TBL] [Abstract][Full Text] [Related]
11. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
[TBL] [Abstract][Full Text] [Related]
12. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.
Aberg JA; Williams PL; Liu T; Lederman HM; Hafner R; Torriani FJ; Lennox JL; Dube MP; MacGregor RR; Currier JS;
J Infect Dis; 2003 Apr; 187(7):1046-52. PubMed ID: 12660918
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.
Sterling TR; Moore RD; Graham NM; Astemborski J; Vlahov D; Chaisson RE
AIDS; 1998 Aug; 12(12):1451-7. PubMed ID: 9727565
[TBL] [Abstract][Full Text] [Related]
14. Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study.
Furrer H; Telenti A; Rossi M; Ledergerber B
AIDS; 2000 Jul; 14(10):1409-12. PubMed ID: 10930156
[TBL] [Abstract][Full Text] [Related]
15. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM
Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351
[TBL] [Abstract][Full Text] [Related]
16. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality.
Pasayan MKU; S Mationg ML; Boettiger D; Lam W; Zhang F; Ku SW; Merati TP; Chaiwarith R; Cuong DD; Yunihastuti E; Kiertiburanakul S; Van Kinh N; Avihingsanon A; Sun LP; Kamarulzaman A; Kantipong P; Kumarasamy N; Pujari S; Heng Sim BL; Ng OT; Choi JY; Tanuma J; Ross J; A Ditangco R
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):436-443. PubMed ID: 30550488
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
[TBL] [Abstract][Full Text] [Related]
18. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium avium complex infection in HIV/AIDS patients.
Corti M; Palmero D
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):351-63. PubMed ID: 18588499
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B
Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
